225 related articles for article (PubMed ID: 19145674)
1. p53 gene alterations and human papillomavirus type 16 infection in early stages of cervical carcinoma in Serbia.
Malisic E; Jankovic R; Majkic M; Dobricic J; Radulovic S
J BUON; 2008; 13(4):525-32. PubMed ID: 19145674
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
3. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
[TBL] [Abstract][Full Text] [Related]
5. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
[TBL] [Abstract][Full Text] [Related]
7. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
Nakagawa S; Yoshikawa H; Jimbo H; Onda T; Yasugi T; Matsumoto K; Kino N; Kawana K; Kozuka T; Nakagawa K; Aoki M; Taketani Y
Br J Cancer; 1999 Mar; 79(7-8):1139-44. PubMed ID: 10098748
[TBL] [Abstract][Full Text] [Related]
8. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
9. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
10. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
Zhao W; Si J; Li K
Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
[TBL] [Abstract][Full Text] [Related]
11. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
Li CY; Liu JH; Huang BJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
[TBL] [Abstract][Full Text] [Related]
13. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
14. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.
Andersson S; Rylander E; Strand A; Sällström J; Wilander E
Br J Cancer; 2001 Oct; 85(8):1153-6. PubMed ID: 11710828
[TBL] [Abstract][Full Text] [Related]
15. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil.
Brenna SM; Silva ID; Zeferino LC; Pereira JS; Martinez EZ; Syrjänen KJ
Gynecol Oncol; 2004 May; 93(2):374-80. PubMed ID: 15099948
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in HPV-negative cervical carcinoma.
Park DJ; Wilczynski SP; Paquette RL; Miller CW; Koeffler HP
Oncogene; 1994 Jan; 9(1):205-10. PubMed ID: 8302581
[TBL] [Abstract][Full Text] [Related]
19. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
[TBL] [Abstract][Full Text] [Related]
20. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
